StockNews.com Begins Coverage on Mannatech (NASDAQ:MTEX)

Equities researchers at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a research report issued on Monday. The firm set a “buy” rating on the stock.

Mannatech Stock Performance

NASDAQ MTEX opened at $7.50 on Monday. The firm has a 50-day moving average of $7.37 and a 200-day moving average of $7.71. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.62 and a current ratio of 1.17. The stock has a market cap of $14.14 million, a PE ratio of -8.43 and a beta of 1.17. Mannatech has a 52-week low of $6.75 and a 52-week high of $11.80.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. Mannatech had a negative return on equity of 11.87% and a negative net margin of 0.97%. The business had revenue of $27.74 million during the quarter.

Insiders Place Their Bets

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of Mannatech stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the sale, the director now owns 54,721 shares in the company, valued at approximately $424,087.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 41.50% of the company’s stock.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.